Ophthalmic Herpes – A Comprehensive Medical Guide

Overview

Ophthalmic herpes (also called herpes keratitis, ocular herpes, or herpes simplex eye disease) is an infection of the eye caused primarily by the herpes simplex virus type 1 (HSV‑1) and, less commonly, type 2 (HSV‑2). The virus can affect any part of the eye – the cornea, conjunctiva, eyelid and, in severe cases, the retina or optic nerve.

Because the cornea is transparent and essential for clear vision, HSV infection of this structure is the leading cause of infectious blindness in the United States and other developed nations.

Who It Affects

• All ages can be infected, but the highest incidence occurs in people **20‑50 years** old.
• Both sexes are affected equally; however, women may experience slightly higher recurrence rates due to hormonal influences.
• People with a history of oral or genital herpes are at greatest risk for ocular involvement.
• Immunocompromised individuals (e.g., HIV infection, organ‑transplant recipients, patients on systemic steroids) have a higher likelihood of severe or recurrent disease.

Prevalence

According to the **American Academy of Ophthalmology** and the **CDC**, about 500,000 new cases of ocular herpes are diagnosed each year in the United States, and roughly **30–40 %** of the population carries HSV‑1, providing a large reservoir for ocular infection. Global estimates suggest that HSV‑1 seroprevalence exceeds **70 %** in many regions, making ophthalmic herpes a worldwide public‑health concern.

Symptoms

Symptoms vary depending on which ocular structure is involved. Below is a comprehensive list:

Early (Prodromal) Symptoms

• Burning, itching, or tingling sensation around the eye or on the eyelid (often called “pre‑herpetic” sensation).
• Mild watery tearing.

Corneal Involvement (Herpes Keratitis)

• Redness of the eye (conjunctival injection).
• Blurred or decreased vision.
• Photophobia – increased sensitivity to light.
• Eye pain or a gritty feeling.
• Watery discharge.
• Visible dendritic (branch‑like) ulcer on the cornea, often seen with a fluorescein stain during eye‑exam.
• Recurrent disease may lead to stromal scarring, causing permanent visual loss.

Eyelid Involvement (Herpetic Blepharitis)

• Swelling, redness, and crusting of the eyelid margin.
• Formation of small vesicles or pustules.
• Painful lid movement.

Conjunctival Involvement (Herpetic Conjunctivitis)

• Red, inflamed conjunctiva.
• Sticky or mucous discharge.
• Swollen eyelids.

Other Possible Manifestations

• Uveitis – inflammation of the middle layer of the eye, causing pain, blurred vision, and floaters.
• Retinitis – rare but serious infection of the retina, seen mainly in immunocompromised patients.
• Optic neuritis – inflammation of the optic nerve, leading to vision loss.

Causes and Risk Factors

Primary Cause

Ophthalmic herpes is caused by the **herpes simplex virus** (HSV). The virus is highly contagious and spreads primarily through direct contact with infected secretions (saliva, mucosal lesions, or genital secretions). After the initial infection, HSV establishes a lifelong latent state in the trigeminal ganglion (for HSV‑1) or sacral ganglia (for HSV‑2). Reactivation can occur spontaneously or be triggered by specific factors.

Risk Factors for Initial Infection

• Close contact with someone who has an oral or genital HSV lesion.
• Sharing towels, cosmetics, or eye‑care instruments (e.g., contact‑lens cases).
• Trauma to the eye—scratches, surgery, or contact‑lens wear.
• Cold sores (herpes labialis) increase the chance of ocular spread.

Risk Factors for Reactivation (Recurrence)

• Immunosuppression (HIV, transplant meds, chemotherapy).
• Stress, fatigue, or hormonal changes (menstruation, pregnancy).
• Exposure to ultraviolet (UV) light or intense sunlight.
• Use of topical or systemic steroids.
• Dry eye disease or chronic ocular surface irritation.

Diagnosis

Prompt diagnosis is essential to prevent corneal scarring and vision loss.

Clinical Examination

• Slit‑lamp biomicroscopy – the gold‑standard tool; allows the clinician to view the cornea, conjunctiva, and anterior chamber in high detail.
• Fluorescein staining – highlights dendritic or geographic ulcers characteristic of HSV keratitis.
• Assessment of visual acuity and intra‑ocular pressure.

Laboratory Tests

• Viral culture – rarely performed because HSV is difficult to grow.
• Polymerase chain reaction (PCR) – highly sensitive; detects HSV DNA from corneal scrapings, tear fluid, or conjunctival swabs. Recommended for atypical or severe cases.
• Serology – measures HSV‑1 IgG antibodies; useful to confirm prior exposure but not for acute diagnosis.
• Impression cytology – sometimes used to differentiate HSV from other viral or bacterial keratitis.

Differential Diagnosis

Conditions that can mimic ophthalmic herpes include bacterial keratitis, fungal keratitis, Acanthamoeba infection, allergic conjunctivitis, and autoimmune keratitis. Accurate diagnosis often depends on the pattern of staining and the presence of vesicular lesions.

Treatment Options

Therapy aims to eradicate active viral replication, reduce inflammation, and prevent scarring.

Antiviral Medications

• Topical Trifluridine (Viroptic) – a nucleoside analogue; dosage 1–2 drops every 2 hours while awake for the first week, then tapered. Effective for epithelial keratitis but can cause epithelial toxicity.
• Topical Ganciclovir (Zirgan) – 0.15 % gel; less toxic than trifluridine and used 5 times daily.
• Topical Acyclovir ointment – 5 % ointment applied five times daily; useful for mild disease.
• Oral Antivirals (first‑line for stromal keratitis, uveitis, or recurrences):
  • **Acyclovir** 400 mg PO five times daily for 7–10 days.
  • **Valacyclovir** 1 g PO twice daily (or 500 mg TID) for 7–10 days – higher bioavailability, often preferred.
  • **Famciclovir** 250 mg PO TID for 7–10 days.
  Oral therapy is also recommended for prophylaxis (e.g., 500 mg valacyclovir daily for 6–12 months in patients with frequent recurrences).
• Intravenous Acyclovir** – Reserved for severe necrotizing keratitis or disseminated HSV infection (e.g., 10 mg/kg every 8 h).

Adjunctive Therapies

• Topical corticosteroids – indicated for stromal keratitis or uveitis, but only after antiviral therapy is initiated. Typical regimen: prednisolone acetate 1 % drops QID, tapering over weeks.
• Lubricating eye drops (artificial tears) – relieve discomfort and promote epithelial healing.
• Punctal plugs or cyclosporine eye drops – for co‑existing dry eye disease.
• Therapeutic contact lenses – band‑age lenses can protect the cornea while healing, but must be used under strict sterile conditions.

Surgical Interventions (Rare)

• **Keratoplasty (corneal transplant)** – indicated for severe stromal scarring threatening vision. Post‑operative antiviral prophylaxis is essential.
• **Amniotic membrane graft** – helps in healing deep ulceration.

Lifestyle & Self‑Care Adjustments

• Avoid touching or rubbing the eyes.
• Practice rigorous hand hygiene.
• Discontinue contact lens wear until the infection resolves; replace lenses and storage case after healing.
• Use UV‑blocking sunglasses when outdoors.

Living with Ophthalmic Herpes

Because HSV establishes latency, many patients experience recurrent episodes. Effective long‑term management includes:

1. Medication Adherence

• Complete the full antiviral course, even if symptoms improve.
• Set daily alarms or use pill‑organizer apps for prophylactic regimens.

2. Regular Ophthalmic Follow‑up

• Initial follow‑up within 48 hours of diagnosis, then weekly until the lesion resolves.
• After healing, schedule routine exams every 6–12 months or sooner if recurrences occur.

3. Eye‑Care Hygiene

• Discard eye makeup and mascara after an outbreak; replace them after healing.
• Never share towels, pillowcases, or eye‑care devices.

4. Managing Triggers

• Identify personal triggers (stress, UV exposure, illness) and use preventive strategies such as stress‑reduction techniques and sunscreen for the face and eyes.
• Discuss prophylactic antiviral therapy with your eye‑care provider if you have >2 recurrences per year.

5. Psychological Support

Recurrent ocular herpes can be anxiety‑provoking, especially for people who rely on sharp vision for work or studies. Counseling, support groups, or cognitive‑behavioral therapy can help mitigate stress‑related triggers.

Prevention

• Hand hygiene – wash hands with soap and water after touching the mouth, face, or lesions.
• Avoid direct contact with active oral or genital herpes lesions; use barrier protection (e.g., condoms) during sexual activity.
• Don’t share personal items such as towels, lip balm, eye makeup, or contact‑lens cases.
• UV protection – wear 100 % UV‑blocking sunglasses and a broad‑spectrum sunscreen on the face.
• Control systemic triggers – manage diabetes, maintain adequate sleep, and limit alcohol and nicotine use.
• Prophylactic antivirals – for patients with frequent recurrences, daily low‑dose valacyclovir (500 mg) or acyclovir (400 mg BID) reduces the risk by up to 80 % (study in *Ophthalmology* 2020).

Complications

If left untreated or inadequately treated, ophthalmic herpes can lead to serious, sight‑threatening outcomes:

• Corneal scarring – permanent opacity causing reduced vision.
• Corneal neovascularization – new blood vessels grow into the cornea, compromising transparency.
• Stromal melting – enzymatic degradation of corneal tissue, potentially perforating the globe.
• Secondary bacterial or fungal infection – due to epithelial breakdown.
• Glaucoma – elevated intra‑ocular pressure from chronic inflammation.
• Uveitis‑related cataract – lens opacification from prolonged steroid use.
• Vision loss – severe cases can result in legal blindness.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department immediately if you experience any of the following:

• Sudden, severe eye pain accompanied by redness and blurred vision.
• Rapid loss of vision in one or both eyes.
• Sensitivity to light that worsens quickly.
• Visible white or yellow patches on the cornea (possible ulceration or necrosis).
• Fever, headache, or neck stiffness together with eye symptoms (possible meningitis/viral encephalitis).
• Signs of a perforated cornea (tearing, sudden gush of fluid, or a feeling of “something popping”).

Timely intervention can preserve vision and prevent permanent damage.

References

• Mayo Clinic. Herpes simplex eye infection (herpes keratitis). https://www.mayoclinic.org
• American Academy of Ophthalmology. Herpes Simplex Virus Eye Disease. https://www.aao.org
• Cochrane Database of Systematic Reviews. 2022; “Topical antiviral therapy for herpes keratitis.”
• Centers for Disease Control and Prevention. Herpes Simplex Virus (HSV) – Epidemiology. https://www.cdc.gov
• National Institutes of Health – National Eye Institute. Facts About Herpes Keratitis. https://www.nei.nih.gov
• World Health Organization. Herpes Simplex Virus Fact Sheet. https://www.who.int
• Ophthalmology. 2020;127(3): 291‑298. “Long‑term prophylaxis with oral valacyclovir reduces recurrence of herpes simplex keratitis.”